ALGS

Quote

Short

News

Articles

Message Board

Aligos Therapeutics Inc. (NASDAQ : ALGS ) News

News Releases

ALGS News Releases

May 27, 2026 02:30:00 am

GlobeNewswire

Aligos Therapeutics Presents Positive Data at the EASL Congress 2026

May 13, 2026 02:05:00 am

GlobeNewswire

Aligos Therapeutics Announces Ten Abstracts Accepted for Presentation at the EASL Congress 2026

May 07, 2026 05:53:23 pm

SeekingAlpha

Aligos Therapeutics GAAP EPS of -$2.21 beats by $0.04, revenue of $2.83M beats by $2.5M

May 07, 2026 04:05:00 pm

GlobeNewswire

Aligos Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results

April 30, 2026 04:05:00 pm

GlobeNewswire

Aligos Therapeutics to Announce 1st Quarter 2026 Financial Results on May 7, 2026

April 24, 2026 08:00:00 am

GlobeNewswire

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

April 16, 2026 07:16:58 am

SeekingAlpha

Aligos Therapeutics jumps 22% on Greater China deal for Hepatitis B drug

April 16, 2026 06:00:00 am

GlobeNewswire

Aligos Therapeutics Enters into Exclusive License Deal with Xiamen Amoytop Biotech Co., Ltd. to Develop and Commercialize Pevifoscorvir Sodium in Greater China for Chronic Hepatitis B Virus Infection

April 14, 2026 04:05:00 pm

GlobeNewswire

Aligos Therapeutics Announces First Interim Analysis Results from the Phase 2 B-SUPREME Study of Pevifoscorvir Sodium in Participants with Chronic Hepatitis B Virus Infection and Grant of FDA Fast Track Designation

March 05, 2026 01:02:25 pm

SeekingAlpha

Aligos Therapeutics GAAP EPS of -$1.91 beats by $0.12

	Next 10

Subscribe to Our Newsletter

Download The Market Wire News App

Link Market Wire News to Your X Account